Insights
Search Results
Newsletters
2.22.24
2023 Technology and Life Sciences PIPE and RDO Report
Wilson Sonsini’s 2023 Technology and Life Sciences PIPE and RDO Report presents analysis related to 177 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and December 31, 2023. PIPEs and RDOs can be good alternatives to traditional underwritten offerings, particularly during periods of market volatility, because they can be negotiated discreetly and publicly announced after the parties agree to terms.
Newsletters
9.13.23
2023 Mid-Year Technology and Life Sciences PIPE and RDO Report
We present analysis related to 87 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and June 30, 2023. The report is limited to transactions in which the company raised at least $10 million and had at least one closing in the first half of 2023.
Newsletters
4.26.23
2022 Technology and Life Sciences PIPE Report
In this inaugural issue, we present analysis related to 108 private investments in public equity (PIPEs) by U.S.-based technology and life sciences companies between January 1 and December 31, 2022, in which each company raised at least $10 million.